China Pioneer Pharma Holdings Ltd - ESG Rating & Company Profile powered by AI
This report of China Pioneer Pharma Holdings Ltd leverages data from across the internet as well as from public filings by China Pioneer Pharma Holdings Ltd. The Disclosure rating covers 17 UN SDGs including: 'Quality Education', 'Climate Action' and 'Peace, Justice & Strong Institutions'. Other companies in the scoring peer group for China Pioneer Pharma Holdings Ltd are displayed.
China Pioneer Pharma Holdings Ltd in the Drug Retailers industry gained a UN SDG ESG Transparency Score of 0.7; made up of an environmental score of 0.0, social score of 0.0 and governance score of 2.0.
0.7
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Sapporo Clinical Laboratory Inc | 8.0 | High |
2 | Nihon Chouzai Co Ltd | 7.5 | High |
... | ... | ... | |
60 | Qol Holdings Co Ltd | 0.9 | Low |
60 | Wanjia Group Holdings Ltd | 0.9 | Low |
64 | China Pioneer Pharma Holdings Ltd | 0.7 | Low |
64 | Nova Cannabis Inc | 0.7 | Low |
64 | Arich Enterprise Co Ltd | 0.7 | Low |
70 | Zhejiang Zhenyuan Share Co Ltd | 0.0 | Low |
70 | d1000 Varejo Farma Participacoes SA | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does China Pioneer Pharma Holdings Ltd have an accelerator or VC vehicle to help deliver innovation?
Does China Pioneer Pharma Holdings Ltd disclose current and historical energy intensity?
Does China Pioneer Pharma Holdings Ltd report the average age of the workforce?
Does China Pioneer Pharma Holdings Ltd reference operational or capital allocation in relation to climate change?
Does China Pioneer Pharma Holdings Ltd disclose its ethnicity pay gap?
Does China Pioneer Pharma Holdings Ltd disclose cybersecurity risks?
Does China Pioneer Pharma Holdings Ltd offer flexible work?
Does China Pioneer Pharma Holdings Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does China Pioneer Pharma Holdings Ltd disclose the number of employees in R&D functions?
Does China Pioneer Pharma Holdings Ltd conduct supply chain audits?
Does China Pioneer Pharma Holdings Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does China Pioneer Pharma Holdings Ltd conduct 360 degree staff reviews?
Does China Pioneer Pharma Holdings Ltd disclose the individual responsible for D&I?
Does China Pioneer Pharma Holdings Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does China Pioneer Pharma Holdings Ltd disclose current and / or historical scope 2 emissions?
Does China Pioneer Pharma Holdings Ltd disclose water use targets?
Does China Pioneer Pharma Holdings Ltd have careers partnerships with academic institutions?
Did China Pioneer Pharma Holdings Ltd have a product recall in the last two years?
Does China Pioneer Pharma Holdings Ltd disclose incidents of discrimination?
Does China Pioneer Pharma Holdings Ltd allow for Work Councils/Collective Agreements to be formed?
Has China Pioneer Pharma Holdings Ltd issued a profit warning in the past 24 months?
Does China Pioneer Pharma Holdings Ltd disclose parental leave metrics?
Does China Pioneer Pharma Holdings Ltd disclose climate scenario or pathway analysis?
Does China Pioneer Pharma Holdings Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does China Pioneer Pharma Holdings Ltd disclose the pay ratio of women to men?
Does China Pioneer Pharma Holdings Ltd support suppliers with sustainability related research and development?
Does China Pioneer Pharma Holdings Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does China Pioneer Pharma Holdings Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is China Pioneer Pharma Holdings Ltd involved in embryonic stem cell research?
Does China Pioneer Pharma Holdings Ltd disclose GHG and Air Emissions intensity?
Does China Pioneer Pharma Holdings Ltd disclose its waste policy?
Does China Pioneer Pharma Holdings Ltd report according to TCFD requirements?
Does China Pioneer Pharma Holdings Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does China Pioneer Pharma Holdings Ltd disclose energy use targets?
Does China Pioneer Pharma Holdings Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does China Pioneer Pharma Holdings Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for China Pioneer Pharma Holdings Ltd
These potential risks are based on the size, segment and geographies of the company.
China Pioneer Pharma Holdings Limited, an investment holding company, markets, promotes, and sells pharmaceutical products and medical devices primarily in the People's Republic of China. It has a portfolio of pharmaceutical products, such as ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas, as well as medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company sells its products to hospitals and medical institutions, and pharmacies. It also sells ancillary tools and leases accessories; and sells dental devices. In addition, the company engages in the sale of imported in-licensed prescription products. China Pioneer Pharma Holdings Limited was founded in 1996 and is headquartered in Shanghai, the People's Republic of China. China Pioneer Pharma Holdings Limited is a subsidiary of Pioneer Pharma (BVI) Co., Ltd.